Possible role of gadolinium in nephrogenic systemic fibrosis: Report of two cases and review of the literature

Clinical and Experimental Dermatology

Volumn 32, Issue 4, 2007, Pages 353-358

  Lim, Y L ^a,b   Lee, H Y ^a   Low, S C S ^a   Chan, L P ^a   Goh, N S G ^a   Pang, S M ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CONTRAST MEDIUM; GADODIAMIDE;

ADULT; AGED; ARTICLE; CASE REPORT; DERMIS; DISEASE SEVERITY; DRUG EXPOSURE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PRECIPITATION; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; TISSUE INJURY;

ADULT; AGED; CONTRAST MEDIA; FIBROSIS; GADOLINIUM; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; SKIN DISEASES;

EID: 34249693587     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02412.x     Document Type: Article

References (23)

1. Cowper SE, Robin HS, Steinberg SM et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000 356 : 1000 1.
2. Ting WW, Stone MS, Madison KC et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003 139 : 928 30.
3. Swartz RD, Crofford LJ, Phan SH et al. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003 114 : 563 72.
4. January F, Segal JM, Dyer J et al. Nephrogenic fibrosing dermopathy. Two pediatric cases. J Pediatr 2003 143 : 678 81.
5. Cassis TB, Jackson JM, Sonnier GB et al. Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol 2006 45 : 56 9.
6. Mackay-Wiggan JM, Cohen DJ, Hardy MA et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003 48 : 55 60.
7. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006 21 : 1104 8.
8. Leboit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003 139 : 928 30.
9. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis. suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006 17 : 2359 62.
10. Tan AWH, Tan SH, Lian TY et al. A case of nephrogenic fibrosis dermopathy. Ann Acad Med Singapore 2004 33 : 527 9.
11. Prince MR, Contrast-enhanced MR angiography. theory and optimization. Magn Reson Imaging Clin N Am 1998 6 : 257 67.
12. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007 56 : 27 30.
13. High WA, Ayers RA, Chandler J et al. Gadolinium is detectable within tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007 56 : 21 6.
14. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000 12 : 205 13.
15. Center for Drug Evaluation and Research, US Food and Drug Adminstration. Public Health Advisory : Update on magnetic resonance imaging (mri) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy, 2006. Available at: http://www.fda.gov/cder/drug/advisory/gadolinium_agents_20061222. htm. Accessed 10 January 2007.
16. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 2003 25 : 358.
17. Mendoza FA, Artlett CM, Sandorfi N et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 2006 35 : 238 49.
18. Cowper SE. Nephrogenic fibrosing dermopathy: the first six years. Curr Opin Rheumatol 2003 15 : 785 90.
19. DeHoratius DM, Cowper SE. Nephrogenic systemic fibrosis: an emerging threat among renal patients. Semin Dial 2006 19 : 191 4.
20. Chung HJ, Chung KY. Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin. Br J Dermatol 2004 150 : 596 7.
21. Maloo M, Abt P, Kashyap R et al. Nephrogenic systemic fibrosis among liver transplant recipients. A single institution experience and topic update. Am J Transplant 2006 6 : 2212 7.
22. Streams BN, Liu V, Liegeois N et al. Clinical and pathological features of nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2003 48 : 42 7.
23. Gilliet M, Cozzio A, Burg G et al. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 2005 152 : 531 6.